109 - Novel Insights into NTM

Speaker(s)

• SH

  Steven Holland, MD

  Dr.
  National Institutes of Allergy and Infectious Diseases
  Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  Bethesda, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Shannon H. Kasperbauer, MD

  Associate Professor of Medicine
  Division of Mycobacterial and Respiratory Infections, National Jewish Health
  Denver, Colorado

  Disclosure: Insmed : Advisor or Review Panel member (Status: Ongoing), Speaker (Status: Ongoing); Paratek : Other Financial or Material Support (Status: Ongoing), Speaker (Status: Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-433-H01-P

Learning Objectives:

• define mechanisms responsible for abnormal immune function which increase risk of disseminated mycobacterial infection
• explain recent advances in the treatment of nontuberculous mycobacteria including antimicrobials and non-antimicrobial based therapies
• discuss recent clinical advances and discoveries that have the potential to impact clinical care and foster new research

Presentations:

• 11:00am – 12:15pm EDT

  Novel Insights into NTM - Speaker 1
  Steven M. Holland, MD – Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health
• 11:00am – 12:15pm EDT

  Novel Insights into NTM - Speaker 2
  Shannon H. Kasperbauer, MD – Division of Mycobacterial and Respiratory Infections, National Jewish Health